To implement the Opinions of the General Office of the State Council on Promoting the High-quality Development of Public Hospitals (GBF [2021] No. 18), the National Health Commission of the People's Republic of China selected 14 hospitals in nine provinces across the country as pilot hospitals for the high-quality development of public hospitals in July 2021. The University of Hong Kong - Shenzhen Hospital was on the list, together with Peking Union Medical College Hospital, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, and other top hospitals.

The establishment of the HKU-SZH represents a fresh move for the medical cooperation between Shenzhen and Hong Kong against the backdrop of the "One Country, Two Systems," and the Hospital currently shoulders the tremendous historical opportunities brought by the establishment of the Guangdong-Hong Kong-Macao Greater Bay Area and Shenzhen Pilot Demonstration Area of Socialism with Chinese Characteristics. Following the "3+1" strategies with the initial letter "i" (i.e. Internationalization, Innovation, Interdisciplinarity and Impact) proposed by the University of Hong Kong, it is built with the idea of eyeing the development of the Guangdong-Hong Kong-Macao Greater Bay Area and aligning with international standards. The Hospital has carried out green healthcare reform initiatives to strengthen innovations in institution, technology, development and governance. Taking the lead in exploring paths for high-quality development of public hospitals, it seeks to transform the development mode from scale expansion to quality and efficiency improvement, the operation mode from extensive management to delicacy management, and the resource allocation from production material-oriented to talent and technology-oriented.

14 Pilot Hospitals for High-Quality Development of Public Hospitals in China

Overall Objectives

We intend to build HKU-SZH into a patient-centred, well-functioned and intelligent modern hospital in the following 5-10 years. It is expected to gradually increase the Case Mix Index (CMI) value of HKU-SZH to around 2, and enlarge the proportion of level 4 surgery, technical service income in total medical income, personnel expenditure in business expenditure, and fixed salary in personnel compensation to about 60% or more. 

By 2025, the development level of key specialties in HKU-SZH will catch up with Queen Mary Hospital of the University of Hong Kong. An international medical centre in the Guangdong-Hong Kong-Macao Greater Bay Area that integrates medical treatment, scientific research, teaching, and disease prevention will be built, leading the development of green healthcare reform.

By 2030, we will make HKU-SZH a first-class and internationally renowned medical centre, with top-level medical scientific and technological innovation, talent training, and hospital management innovation, as well as a benchmark hospital for the high-quality development of public hospitals in China.